We are live on
!
Find out more
VIA
Vident Investment Advisory Portfolio holdings
AUM
$2.9B
1-Year Est. Return
24.67%
This Fund
S&P 500
This Quarter
Est. Return
-16.08%
1 Year Est. Return
+24.67%
3 Year Est. Return
+82.63%
5 Year Est. Return
+113.33%
10 Year Est. Return
–
AUM
$1.79B
AUM Growth
-$769M
(-30%)
Cap. Flow
-$325M
Cap. Flow
% of AUM
-18.19%
Top 10 Holdings %
Top 10 Hldgs %
13.27%
Holding
993
New
75
Increased
285
Reduced
405
Closed
227
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$22.8M |
| 2 |
Globus Medical
GMED
|
+$13.6M |
| 3 |
MTLS
Materialise
MTLS
|
+$13.3M |
| 4 |
ABB
ABB Ltd
ABB
|
+$13.1M |
| 5 |
BEAT
BioTelemetry, Inc.
BEAT
|
+$11.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zebra Technologies
ZBRA
|
+$12.4M |
| 2 |
Intuitive Surgical
ISRG
|
+$10.6M |
| 3 |
XLNX
Xilinx Inc
XLNX
|
+$9.57M |
| 4 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$9.34M |
| 5 |
Rockwell Automation
ROK
|
+$8.77M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.01% |
| 2 | Healthcare | 13.46% |
| 3 | Industrials | 11.37% |
| 4 | Consumer Discretionary | 8% |
| 5 | Financials | 6.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Portland General Electric
POR
$5.77B
| $2.65M | 0.15% |
57,877
-16,813
| -23% | -$788K |
|
152
Equinix
EQIX
$103B
| $2.64M | 0.15% |
7,497
+1,480
| +25% | +$577K |
|
153
Best Buy
BBY
$17.3B
| $2.63M | 0.15% |
49,570
-9,401
| -16% | -$614K |
|
154
Globe Life
GL
$14.3B
| $2.62M | 0.15% |
35,178
+131
| +0.4% | +$10.9K |
|
155
Old Republic International
ORI
$10.4B
| $2.6M | 0.15% |
126,475
-20,536
| -14% | -$440K |
|
156
Jabil
JBL
$35.8B
| $2.6M | 0.15% |
104,889
-13,964
| -12% | -$341K |
|
157
Cognizant
CTSH
$26B
| $2.6M | 0.15% |
40,936
-4,574
| -10% | -$318K |
|
158
F5
FFIV
$22.7B
| $2.6M | 0.15% |
16,029
-5,321
| -25% | -$913K |
|
159
Cal-Maine
CALM
$3.99B
| $2.59M | 0.15% |
61,203
-10,529
| -15% | -$488K |
|
160
Designer Brands
DBI
$333M
| $2.59M | 0.15% |
104,803
-32,726
| -24% | -$878K |
|
161
CACI
CACI
$14.2B
| $2.58M | 0.14% |
17,912
-379
| -2% | -$64.5K |
|
|
CVSA
162
Covista Inc
CVSA
$4.8B
| $2.56M | 0.14% |
54,072
-4,694
| -8% | -$240K |
|
163
Infosys
INFY
$50.7B
| $2.55M | 0.14% |
267,996
-10,440
| -4% | -$99.7K |
|
164
Synchrony
SYF
$25.6B
| $2.52M | 0.14% |
107,541
-9,640
| -8% | -$261K |
|
165
Williams-Sonoma
WSM
$29.6B
| $2.52M | 0.14% |
99,988
-62,054
| -38% | -$1.77M |
|
166
FTI Consulting
FCN
$4.18B
| $2.51M | 0.14% |
37,640
-5,273
| -12% | -$354K |
|
167
Usana Health Sciences
USNA
$286M
| $2.51M | 0.14% |
21,299
-2,983
| -12% | -$345K |
|
168
Gentex
GNTX
$5.07B
| $2.5M | 0.14% |
123,785
-16,104
| -12% | -$337K |
|
169
Darling Ingredients
DAR
$9.44B
| $2.5M | 0.14% |
129,806
-18,205
| -12% | -$369K |
|
170
Sabre
SABR
$835M
| $2.48M | 0.14% |
114,769
-47,680
| -29% | -$1.15M |
|
171
Kemper
KMPR
$1.68B
| $2.48M | 0.14% |
37,390
-5,237
| -12% | -$382K |
|
172
Simon Property Group
SPG
$72.3B
| $2.48M | 0.14% |
14,767
+1,923
| +15% | +$344K |
|
173
Invesco Senior Income Trust
VVR
$454M
| $2.48M | 0.14% |
634,278
-8,766
| -1% | -$36.2K |
|
174
Seagate
STX
$184B
| $2.48M | 0.14% |
64,144
-1,307
| -2% | -$55K |
|
175
Avnet
AVT
$7.92B
| $2.47M | 0.14% |
68,380
-8,709
| -11% | -$356K |
|
Similar funds
EST
TCM
AWS
WI
JP
VCM
FCB
FCFS
Vident Investment Advisory's Q4 2018 Portfolio in Review
As of Q4 2018, Vident Investment Advisory held 993 positions worth $1.79B, down 30% from $2.55B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Vident Investment Advisory withdrew a net $325M in Q4 2018, closing 227 positions and reducing 405 holdings. Its most notable exit was Lazard, an estimated $3.82M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 27% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Vident Investment Advisory opened a new position in Globus Medical worth $11.8M.
- Vident Investment Advisory's largest Q4 2018 buy was Globus Medical: 272,897 shares worth $11.8M.
- Vident Investment Advisory added most to State Street SPDR S&P 500 ETF Trust in Q4 2018, an estimated $22.8M increase.
- Vident Investment Advisory's biggest Q4 2018 reduction was Zebra Technologies, cutting an estimated $12.4M.
- Vident Investment Advisory fully exited Lazard in Q4 2018, selling an estimated $3.82M.
- Vident Investment Advisory's ten largest holdings make up 13% of its $1.79B portfolio in Q4 2018.
- Vident Investment Advisory opened 75 new positions and closed 227 in Q4 2018.
- Vident Investment Advisory's portfolio value fell 30% quarter-over-quarter to $1.79B.
Based on Vident Investment Advisory's 13F filing for Q4 2018, filed 14 Feb 2019.